Clinical Trials

50 enrolled

Colorectal Neoplasms

NCT07381777 2026-02-02

IMMUNOSTAR

270 enrolled

Locally Advanced Rectal Cancer (LARC)

NCT07229846 2026-01-08

A Single-arm, Single-center, Phase II Clinical Study of Aipalolitovorelizumab (QL1706) Combined With Bevacizumab and Standard Chemotherapy as First-line Treatment for MSS/pMMR Metastatic Colorectal Cancer With BRAF V600E Mutation

30 enrolled

Colorectal Neoplasms

NCT07127497 2025-11-21

Clinical Study on the Safety and Relationship of Sintilimab Combined With Chemotherapy in Neoadjuvant Treatment of Locally Advanced Rectal Adenocarcinoma

50 enrolled

Rectal Neoplasms

NCT07007182 2025-09-05

Conversion Therapy Plus Surgery and Radiotherapy for Retroperitoneal Nodal Metastases in Gastric Cancer

54 enrolled

Stomach Neoplasms

NCT07156682 2025-09-05

QL1706 Plus XELOX as Neoadjuvant Therapy for MSS/pMMR Clinical Stage III Colon Cancer

21 enrolled

Colonic Neoplasms

NCT07108127 2025-08-06

NePHera

24 enrolled

Rectal Neoplasms

NCT01643070 2025-02-25

Preoperative CRT With or Without Induction Chemotherapy for Rectal Cancer With Liver Metastases

38 enrolled 16 charts

Rectal Neoplasms

NCT04380337 2025-02-25

Organ Preservation Program Using Short-Course Radiation & FOLFOXIRI in Rectal Cancer

38 enrolled 13 charts

Rectal Neoplasms

NCT06808412 2025-02-05

To Explore the Efficacy of Sintilimab Combined with Bevacizumab in Rectal Cancer

118 enrolled

Rcctal Cancer

NCT06475352 2025-01-27

FUDOSE

400 enrolled

Gastrointestinal Neoplasms, Neoplasm Metastasis, Neoplasms, Recurrence, Colorectal Neoplasms

NCT03565029 2024-12-27

NO-CUT

180 enrolled

Colonic Neoplasms, Rectal Neoplasms

NCT01531595 2024-12-12

AXOAXI

100 enrolled

Colorectal Neoplasms

NCT06242418 2024-12-12

REVISE

60 enrolled

Colonic Neoplasms

NCT05086627 2024-08-22

Short-course Radiotherapy Followed by Tislelizumab + CapeOX in the Treatment for Locally Advanced Rectal Cancer

118 enrolled

Locally Advanced Rectal Cancer

NCT06506292 2024-07-17

A Phase II Trial of Perioperative Adebrelimab Combined With XELOX in Resectable Locally Advanced Gastric/Gastroesophageal Junction Cancer (GC/GEJC)

25 enrolled

Adebrelimab (SHR-1316)

NCT03714490 2024-05-29

SUNRISE

200 enrolled

Rectal Neoplasms

NCT06023758 2024-05-10

Phase 2 Trial of KN026+KN046±XELOX in HER2-positive Locally Advanced GC

18 enrolled

HER2-positive Locally Advanced Resectable Gastric Cancer

NCT05228431 2024-04-22

Modified Sandwich Therapeutic Regimen for Locally Advanced Rectal Cancer

121 enrolled

Rectal Neoplasms

NCT04543695 2024-03-26

A Study of Total Neoadjuvant Therapy for High-risk Locally Advanced Rectal Cancer

255 enrolled

Rectal Neoplasms

NCT05494060 2023-11-07

EXPLORING

80 enrolled

Carcinoma, Digestive System Diseases, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Stomach Neoplasms

NCT03840239 2023-10-25

TESS

98 enrolled

Rectal Neoplasms

NCT05985707 2023-08-21

KN026 Plus Chemotherapy ± KN-046 in HER2 Positive Colorectal Cancer and Biliary Carcinoma

80 enrolled

HER2-positive Colorectal Cancer

NCT04659382 2023-08-18

SIRTCI

52 enrolled

Colorectal Neoplasms

NCT05969847 2023-08-01

TRACE-LE

72 enrolled

Rectal Neoplasms

NCT05420584 2023-05-11

NECI

83 enrolled

Rectal Neoplasms

NCT04744649 2022-11-15

NICE

110 enrolled

Stomach Neoplasms

NCT05545436 2022-09-22

Carrelizumab (PD-1) Combined With Chemotherapy in Neoadjuvant Treatment of Locally Advanced Gastric Cancer

34 enrolled

Locally Advanced Gastric Cancer

NCT05468138 2022-08-26

PD-1 Antibody Adjuvant Therapy for GC Patients With MSI-H After D2 Radical Surgery

141 enrolled

Stomach Neoplasms

NCT03666442 2022-04-29

Early Evaluation of Chemosensitivity for Low/Intermediated-risk Mid-low Stage II/III Rectal Cancer

61 enrolled

Rectal Neoplasms

NCT05193292 2022-01-14

Camrelizumab Combined With Trastuzumab and Chemotherapy in Patients With HER2-positive Advanced Colorectal Cancer

77 enrolled

Intestinal Neoplasms, Colorectal Neoplasms

NCT04418895 2021-11-10

Neoadjuvant Therapy for Localized Rectal Adenocarcinoma

Phase 2 Withdrawn

Rectal Neoplasms

NCT03484221 2021-04-14

Totally Neoadjuvant FOLFOXIRI + Short-course Radiation + XELOX in Patients With Locally Advanced Rectal Cancer

30 enrolled

Rectal Neoplasms

NCT03229096 2019-06-28

Apatinib Plus XELOX as Neoadjuvant Therapy in Locally Advanced Gastric Cancer

35 enrolled

Stomach Neoplasms

NCT03511170 2018-05-01

XELOX and XELIRI Alternative Regimen as First-line Treatment for Advanced Colorectal Cancer

66 enrolled

Colorectal Neoplasms

NCT03511183 2018-05-01

XELOX+Bevacizumab and XELIRI + Bevacizumab Alternative Regimen as First-line Treatment for Advanced Colorectal Cancer

66 enrolled

Colorectal Neoplasms

NCT00127036 2017-03-23

Trial for Microarray Analysis of Colon Cancer Outcome-A (MACCO-A)

Phase 2 Terminated

65 enrolled 8 charts

Adenocarcinoma, Colonic Neoplasms, Rectal Neoplasms

NCT02870153 2016-08-19

SOX Versus XELOX for Patients With Peritoneal Metastasis of Colorectal Cancer

60 enrolled

Colorectal Neoplasms

NCT01618474 2015-12-22

Trial of Adjuvant Chemotherapy for High Risk Gastric Cancer Patients

100 enrolled

Stomach Neoplasms

NCT02291744 2015-11-11

A Phase Ⅱ Study of XELOX Chemotherapy With or Without Surgery of Primary Lesion for Colon Cancer Patients

130 enrolled

Colonic Neoplasms

NCT00378066 2013-01-23

Phase II Study of Bevacizumab, Capecitabine and Oxaliplatin in Colon Cancer

49 enrolled

Colorectal Neoplasms

NCT00677144 2012-10-05

Oxaliplatin and S-1 (OS) Versus Oxaliplatin and Capecitabine (XELOX) for Advanced Colorectal Cancer

88 enrolled

Colorectal Neoplasms

NCT00220116 2010-01-06

Phase II Trial Assessing Efficacy and Toxicity of Capecitabine and Oxaliplatin in the Treatment of Colorectal Cancer

172 enrolled

Colorectal Neoplasms

NCT00997685 2009-10-19

Evaluate Efficacy and Safety of XELOX in Potentially Resectable Liver Metastasis From Colorectal Cancer(CRC)

110 enrolled